✦ LIBER ✦

ALK Inhibition for Non-Small Cell Lung Cancer: From Discovery to Therapy in Record Time

✍ Scribed by David E. Gerber; John D. Minna

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Is Overall Treatment Time a Predictive F

✍ Bremjit, P.J.; Robinson, G.D.; Weaver, R.L.; Bowen, S.R.; Rengan, R.; Patel, S.A 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 72 KB

Nuclear excision repair-based personaliz

✍ George R. Simon; Roohi Ismail-Khan; Gerold Bepler 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 795 KB

The impact of overall treatment time on

✍ Chen, Ming; Jiang, Guo-Liang; Fu, Xiao-Long; Wang, Li-Juan; Qian, Hao; Chen, Gui 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 117 KB

Individualizing Therapy for Non–Small-Ce

✍ David R. Gandara; Primo N. Lara Jr; Philip Mack; Giorgio Scagliotti 📂 Article 📅 2009 🏛 CIG Media Group, LP. 🌐 English ⚖ 457 KB

Radiation Therapy for Brain Metastases i

✍ Mak, K.S.; Gainor, J.F.; Niemierko, A.; Oh, K.S.; Willers, H.; Choi, N.C.; Loeff 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 46 KB

369 Timing of responses to crizotinib (P

✍ B. Solomon; Y.J. Bang; D.R. Camidge; A.J. Iafrate; E.L. Kwak; R.G. Maki; S.I. Ou 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 45 KB